Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Based Germline Testing for Early Detection and Prevention of Cancer

NCT07498829 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT07498829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07498829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Based Germline Testing for Early Detection and Prevention of Cancer
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Recruiting
Start date
December 18, 2025
Completion date
December 31, 2040
Enrollment
6,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer risk, cancer gene mutation, ovarian cancer risk